Comparative Retrospective Analysis of Skin Tumors of the Eyelids and Face in 2 Brussels University Hospitals Over 5 Years in Dermatology or Ophthalmology

Skin Cancer Clinical Trial

Official title:

Comparative Retrospective Analysis of Skin Tumors of the Eyelids and Face in 2 Brussels University Hospitals Over 5 Years in Dermatology or Ophthalmology

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04886908
• Other study ID #: CHUB-BOULAKHRIF
• Status: Completed
• Start date: February 9, 2021
• Est. completion date: July 28, 2021

Study information

• Verified date: March 2022
• Source: Brugmann University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Skin cancers are the most common of all cancers. Their incidence has increased sharply over the decades.This increase in incidence partly reflects an aging population and behavioral patterns such as repeated exposure to the sun. Indeed, exposure to UV rays is the predominant factor involved in the pathogenesis of these tumors, hence the fact that they mainly develop in photo-exposed regions such as the cephalic extremity.

The objective of this study is to provide an epidemiological analysis of tumors in the populations of both CHU Brugmann and St Pierre hospitals.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 373
• Est. completion date: July 28, 2021
• Est. primary completion date: July 28, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Final diagnosis confirmed by pathological analysis, epidemiological and clinical information available from patients.

Exclusion Criteria:

Patients who have expressed a refusal to access their medical file or incomplete data will not be taken into account.

Related Conditions & MeSH terms

• Skin Cancer
• Skin Neoplasms

Intervention

Other:
• Data extraction from medical files
Data extraction from medical files

Locations

Country	Name	City	State
Belgium	CHU Brugmann	Brussels

Sponsors (1)

Lead Sponsor	Collaborator
Brugmann University Hospital

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Age	Age of the patient at the time of diagnose	5 minutes
Primary	Sex	Sex of the patient	5 minutes
Primary	Name of the department in which the patient is followed	Ophthalmology-CHU Brugmann hospital or Dermatology-CHU Brugmann hospital or Ophthalmology- CHU St Pierre Hospital or Dermatology-CHU St Pierre Hospital	5 minutes
Primary	Tumor anatomical location	Eyelids are distributed in their different regions: internal cantus and external cantus, upper eyelid and lower eyelid. Same for the face: ears, zygomatic, forehead, temples, cheeks, nose, upper lip, lower lip, chin, nasolabial fold, preauricular area, retroauricular area, brow bone.	5 minutes
Primary	Tumor size	Tumor size in millimeters	5 minutes
Primary	Laterality	Laterality: left, right, median	5 minutes
Primary	Multiple or single tumor	Multiple or single tumor	5 minutes
Primary	Primitive tumor or recidive	Primitive tumor or recidive	5 minutes
Primary	Risk factor: phototype	Phototype 1 to 6 on the Fitzpatrick scale. The Fitzpatrick scale is a numerical classification schema for human skin color. Type 1 is pale skin that always burns, never tans and type 6 is deeply pigmented dark brown to darkest brown skin that never burns.	5 minutes
Primary	Risk factor: immunosuppression (yes/no)	Pathogenic or iatrogenic, history of malignant skin tumors other than melanoma, personal or family history of melanoma	5 minutes
Primary	Risk factor: keratosis	Actinic keratosis of the face	5 minutes
Primary	Risk factor: solar exposition (yes/no)	Lived in a sunny European country> 1 year, lived in a sunny country outside Europe> 1 year, sunbed use> 1 session, history of solar erythema during childhood.	5 minutes
Primary	Diagnosis	Time between the appearance of the tumor and the first consultation	5 minutes
Primary	Locoregional extension report (yes/no)	Locoregional extension report (yes/no)	5 minutes
Primary	Histological diagnosis of the tumor	Histological diagnosis of the tumor	5 minutes
Primary	Healthy or invaded margins	Healthy or invaded margins	5 minutes
Primary	Superficial or infiltrating tumor	Superficial or infiltrating tumor	5 minutes
Primary	Diagnostic method	Diagnostic method: curettage, punch, biopsy, flattening	5 minutes
Primary	Surgical management method	Biopsy resection, plasty, graft, second-line healing, enucleation, additional treatment: radiotherapy, immunotherapy, liquid nitrogen	5 minutes